SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950170-23-002427
Filing Date
2023-02-10
Accepted
2023-02-10 08:00:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A final_sch_13ga_2023.htm SC 13G/A 142070
  Complete submission text file 0000950170-23-002427.txt   143433
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Subject) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91717 | Film No.: 23608593
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRELUDE THERAPEUTICS INCORPORATED 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address
Vaddi Krishna (Filed by) CIK: 0001824633 (see all company filings)

Type: SC 13G/A